- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
The Future of PrEP Shots and Potent Treatment: An Advocate's Guide to Long-Acting ARV Injectables
April 7, 2014
This was the third webinar in AVAC's Research & Reality series, a year-long dialogue about prevention research and advocacy. The call provided a forum to learn about and discuss recent data and ongoing research on long-acting ARV injectables.
The term long-acting ARV injectables refers to an antiretroviral drug that is delivered via an injection and persists in the body for an extended period of time. These drugs are being developed to provide therapeutic levels of ARVs (to effectively control HIV as part of combination therapy) for HIV-positive people and protective levels (to reduce the risk of HIV infection) in HIV-negative people for weeks or months at a time.
View the full webinar here.
Location
Webinar
